Comparison of Endothelial Function in Patients with Metabolic Syndrome on Bezafibrate or Atorvastatin Therapy

Author： Hanefeld Christoph   Bulut-Streich Nadine   Bulut Daniel   Graf Claudia   Mügge Andreas   Spiecker Martin  

Publisher： Springer Publishing Company

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.19, Iss.2, 2005-03, pp. : 153-155

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anticoagulant Therapy in Pregnant Patients with Metabolic Syndrome: A Review

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 1, 2014-06 ,pp. : 47-63

Bentham Science Publishers

Access to resources Recommend Favorite

Short-Term Effect of Low-Dose Atorvastatin on Haemorrheological Parameters, Platelet Aggregation and Endothelial Function in Patients with Cerebrovascular Disease and Hyperlipidaemia

By Szapary L.  

CNS Drugs, Vol. 18, Iss. 3, 2004-01 ,pp. : 165-172

Adis International

Access to resources Recommend Favorite

Effects of Rosuvastatin versus Atorvastatin on Rho-associated Coiled-coil Containing Protein Kinase Activity and Endothelial Function in Patients with Atherosclerosis

By Liu B   Cao HM   Li GY   Liu M   Feng J   Li J   Wang Q  

The Journal of International Medical Research, Vol. 39, Iss. 6, 2011-11 ,pp. : 2314-2322

Field House Publishing

Access to resources Recommend Favorite

Pharmacologic Therapy for Cardiovascular Risk Reduction in Patients with the Metabolic Syndrome

By  

Current Pharmaceutical Design, Vol. 20, Iss. 31, 2014-01 ,pp. : 5025-5038

Bentham Science Publishers

Access to resources Recommend Favorite

Antihypertensive Therapy and Endothelial Function

By  

Current Pharmaceutical Design, Vol. 10, Iss. 29, 2004-11 ,pp. : 3607-3614

Bentham Science Publishers

Access to resources Recommend Favorite